Sun Pharma is stepping up regulatory compliance efforts at three USFDA-flagged facilities, including Halol, Mohali, and Dadra.

Sun Pharma aims to enhance compliance and R&D investment for global speciality products, targeting mid to high single-digit ...

Sun Pharmaceutical Industries is addressing regulatory issues at three facilities, including an import alert at Halol.

Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.

Mumbai: Sun Pharma Advanced Research Company Limited (SPARC) has announced the incorporation of its wholly owned subsidiary, ...

Similarly, Aurobindo Pharma is recalling 13,605 bottles of Clorazepate Dipotassium Tablets (3.75 mg and 7.5 mg) from the US market. Clorazepate Dipotassium Tablets are used to treat anxiety.

Sun Pharma later renamed and launched it as Cequa in 2019. In 2021, it acquired the rights to sell Winlevi, a cream to treat acne from Italy-based Cassiopea SpA, in the US and Canada markets.

The EU’s executive commission describes the trade between the U.S. and the EU as “the most important commercial relationship ...

Discover today's top 10 stocks in focus, key Q1 earnings, and major corporate actions - explore the latest market movers now!

Review the current Sun Pharmaceuticals Industries Ltd (524715:XBOM) dividend yield and history to decide if 524715 is the best investment for you.

Review quarterly and annual revenue, net income, and cash flow for Sun Pharma Advanced Research Co Ltd (SPARC:XNSE) stock through the last fiscal year.

The Trump administration has struggled to reach the number of agreements it initially suggested would be possible with the ...